AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
AbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq and Skyrizi take over for Humira, the blockbuster arthritis drug that fueled the company’s growth for more than 15 years.